Detalhe da pesquisa
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34716452
2.
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
PLoS Pathog
; 19(12): e1011780, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38055771
3.
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
J Virol
; 97(2): e0163522, 2023 02 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36749076
4.
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol
; 97(7): e0159622, 2023 07 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37395646
5.
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.
PLoS Pathog
; 16(9): e1008764, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32881968
6.
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
J Infect Dis
; 216(9): 1080-1090, 2017 11 27.
Artigo
Inglês
| MEDLINE | ID: mdl-28968759
7.
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
J Infect Dis
; 213(12): 1946-54, 2016 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26908741
8.
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
J Virol
; 89(15): 7478-93, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25972551
9.
Designing a soluble near full-length HIV-1 gp41 trimer.
J Biol Chem
; 288(1): 234-46, 2013 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-23184960
10.
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
Front Immunol
; 15: 1339727, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38420129
11.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Nat Commun
; 15(1): 3924, 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38724518
12.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38157856
13.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun
; 15(1): 200, 2024 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38172512
14.
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype.
bioRxiv
; 2023 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37745406
15.
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype.
Res Sq
; 2023 Sep 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37841838
16.
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting.
bioRxiv
; 2023 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36712089
17.
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
Front Immunol
; 14: 1138629, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37026013
18.
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study.
EBioMedicine
; 98: 104867, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37939456
19.
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone.
JCI Insight
; 8(9)2023 05 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37154156
20.
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
Nat Commun
; 14(1): 580, 2023 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36737435